Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 66,650 clinical trials worldwide
Search
Showing 4601-4650 of 66,650 trials
Active filters:
Status: Recruiting
Clinical Trials (66,650)
NCT07027293
The Insertion of I-gel and Classic LMA in Different Head Positions in Elderly Patients
NA
Recruiting
120 participants
Started: Jun 20, 2025 · Completed: Sep 15, 2025
4 conditions
1 sponsor
1 location
NCT06364644
Understanding and Addressing Risks of Low Socioeconomic Status and Diabetes for Heart Failure
NA
Recruiting
402 participants
Started: Jun 20, 2025 · Completed: Mar 31, 2027
3 conditions
2 sponsors
2 locations
NCT07077876
Surgical and Obstetric Outcomes in Endometrial Adenocarcinoma and Atypical Endometrial Hyperplasia With Conservative Treatment
N/A
Recruiting
100 participants
Started: Jun 20, 2025 · Completed: Jan 20, 2026
4 conditions
1 sponsor
1 location
NCT07108127
Efficacy and Safety of Trastuzumab Biosimilars and Pertuzumab Biosimilars Combined With Chemotherapy for Neoadjuvant Treatment of Patients With Locally Advanced HER2-positive Rectal Cancer
PHASE2
Recruiting
24 participants
Started: Jun 20, 2025 · Completed: Dec 31, 2026
2 conditions
1 sponsor
1 location
NCT07018518
PIN in Combination With Anti-PD1 in Previously Treated Primary Hepatocellular Carcinoma
PHASE1
Recruiting
25 participants
Started: Jun 20, 2025 · Completed: Dec 1, 2030
2 conditions
2 sponsors
1 location
NCT07022015
Predictive Risk Factors for Pancreatic Fistula After Pancreaticoduodenectomy
NA
Recruiting
100 participants
Started: Jun 20, 2025 · Completed: Jul 20, 2026
7 conditions
1 sponsor
1 location
NCT07001605
Erector Spinae Block Vs Ketamine-based Multimodal Analgesia Protocol in Lumber Decompressive Surgery
NA
Recruiting
62 participants
Started: Jun 20, 2025 · Completed: Sep 30, 2025
4 conditions
1 sponsor
1 location
NCT06959095
Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA -1)
PHASE3
Recruiting
981 participants
Started: Jun 20, 2025 · Completed: Aug 20, 2029
1 condition
1 sponsor
15 locations
NCT06232434
"An Open Prospective Randomized Clinical Study of the Effectiveness, Tolerability and Safety of a Single Intraperitoneal Use of the Drug Prospidelong, Powder for the Preparation of a Gel for Topical Use, 1000 mg in Vials, Package No. 1 in Patients With Disseminated Gastric Cancer, Phase I-II"
PHASE2/PHASE3
Recruiting
120 participants
Started: Jun 20, 2025 · Completed: Dec 31, 2025
1 condition
3 sponsors
1 location
NCT07092228
Evaluation of Exercise Capacity in Teenage Females Using Virtual Reality and Plyometric Workout
NA
Recruiting
100 participants
Started: Jun 20, 2025 · Completed: Oct 30, 2025
1 condition
1 sponsor
1 location
NCT06912776
Novel Visual Education Tool to Improve Recognition and Reporting of Postpartum Urgent Maternal Warning Signs
NA
Recruiting
40 participants
Started: Jun 20, 2025 · Completed: Aug 31, 2026
1 condition
1 sponsor
1 location
NCT07014514
Severity of Sarcopenia in Parkinson's Disease
N/A
Recruiting
80 participants
Started: Jun 20, 2025 · Completed: Oct 31, 2025
1 condition
1 sponsor
1 location
NCT07163273
Monthly Alternating NALIRIFOX and GnP in the First-Line Setting
PHASE2
Recruiting
41 participants
Started: Jun 20, 2025 · Completed: Jun 20, 2027
1 condition
1 sponsor
1 location
NCT07184489
Validation of the Effectiveness of the CFIR - ERIC Matching Tool in Implementation Research
NA
Recruiting
394 participants
Started: Jun 20, 2025 · Completed: Dec 31, 2025
2 conditions
1 sponsor
1 location
NCT06546488
Cognitive Assessment Tools for Huntington's Disease.
N/A
Recruiting
76 participants
Started: Jun 20, 2025 · Completed: Dec 1, 2025
1 condition
1 sponsor
1 location
NCT06954428
Clinical Trial of Intranasal Delivery of NT-301
PHASE1
Recruiting
48 participants
Started: Jun 20, 2025 · Completed: Dec 28, 2025
4 conditions
3 sponsors
2 locations
NCT07012291
Clinical Performance Evaluation of Native Whole Blood Samples of Patients on DOACs With the Perosphere ClotChek™
N/A
Recruiting
150 participants
Started: Jun 20, 2025 · Completed: Jun 1, 2027
1 condition
1 sponsor
4 locations
NCT06980272
SSGJ-707 in Advanced Non-Small Cell Lung Cancer
PHASE3
Recruiting
420 participants
Started: Jun 20, 2025 · Completed: Dec 31, 2028
1 condition
1 sponsor
1 location
NCT06736990
A Phase 2 Study of CAL101 in Patients With Idiopathic Pulmonary Fibrosis
PHASE2
Recruiting
150 participants
Started: Jun 20, 2025 · Completed: Nov 30, 2027
1 condition
1 sponsor
47 locations
NCT07007117
PHOX2B PC-CAR T Cells for Relapsed Neuroblastoma
PHASE1
Recruiting
38 participants
Started: Jun 20, 2025 · Completed: Jun 30, 2035
3 conditions
4 sponsors
1 location
NCT06750484
Trial of Trastuzumab Deruxtecan in Previously Treated HER2
PHASE2
Recruiting
40 participants
Started: Jun 20, 2025 · Completed: Dec 31, 2028
1 condition
3 sponsors
1 location
NCT07206394
Feasibility Trial of ScarWork for Post-breast Surgery Pain Syndrome.
NA
Recruiting
40 participants
Started: Jun 20, 2025 · Completed: Jun 30, 2026
1 condition
2 sponsors
1 location
NCT06410521
Personalised Multicomponent Exercise Programme in Peripheral Arterial Disease
NA
Recruiting
40 participants
Started: Jun 20, 2025 · Completed: Dec 31, 2027
2 conditions
3 sponsors
3 locations
NCT07016646
SH+ and Cash Assistance
NA
Recruiting
40 participants
Started: Jun 20, 2025 · Completed: Dec 20, 2025
2 conditions
2 sponsors
1 location
NCT06014060
24 Versus 12-Month Dual Antiplatelet Therapy After Drug-Eluting Stent in Patients With Elevated Lipoprotein(a) Levels: A Prospective, Multicenter, Double-Blind, Placebo-Controlled Randomized Trial
NA
Recruiting
3,300 participants
Started: Jun 20, 2025 · Completed: Dec 31, 2028
4 conditions
1 sponsor
1 location
NCT06079424
Risk Markers of Arterial Aging. The Paris Prospective Study III-2
N/A
Recruiting
7,500 participants
Started: Jun 20, 2025 · Completed: Dec 31, 2033
1 condition
1 sponsor
1 location
NCT07007273
Pembrolizumab for Advanced Cutaneous Sarcomas Not Including Angiosarcoma
PHASE2
Recruiting
17 participants
Started: Jun 20, 2025 · Completed: Jul 31, 2030
1 condition
2 sponsors
1 location
NCT07015749
A Study to Evaluate the Safety and Tolerability of Multiple Dose of IBI3002 in Patients With Asthma
PHASE1
Recruiting
9 participants
Started: Jun 20, 2025 · Completed: May 20, 2026
1 condition
2 sponsors
1 location
NCT06960018
Clinical Study on the Safety and Efficacy of the Minimally Invasive Ennovate® Method for Pedicle Screw Placement
NA
Recruiting
76 participants
Started: Jun 20, 2025 · Completed: Nov 30, 2028
2 conditions
1 sponsor
3 locations
NCT06891378
At Home, Digital Rehabilitation for Patients After Reverse Total Shoulder Arthroplasty
NA
Recruiting
100 participants
Started: Jun 20, 2025 · Completed: Jun 30, 2026
2 conditions
1 sponsor
1 location
NCT06941753
Off-script Diagnosis & Differential Diagnosis (D&D) Training and Residents' Stroke Knowledge
NA
Recruiting
22 participants
Started: Jun 20, 2025 · Completed: Aug 31, 2027
3 conditions
1 sponsor
1 location
NCT06558877
Effect of a Pharmacist-led Multifaceted Intervention on Treatment Outcomes in Hypertensive Patients
NA
Recruiting
1,200 participants
Started: Jun 20, 2025 · Completed: Dec 31, 2027
1 condition
10 sponsors
1 location
NCT06868082
A Study to Investigate Safety, Tolerability, and Pharmacokinetics of Solrikitug in Healthy Japanese and Non-Japanese Participants
PHASE1
Recruiting
32 participants
Started: Jun 20, 2025 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT07124871
PRP Exosomes Therapy for Erectile Dysfunction
PHASE2
Recruiting
30 participants
Started: Jun 20, 2025 · Completed: May 31, 2026
1 condition
1 sponsor
1 location
NCT06303869
Deep Brain Stimulation Motor Ventral Thalamus (VOP/VIM) for Restoration of Speech and Upper-limb Function in People With Subcortical Stroke
NA
Recruiting
10 participants
Started: Jun 20, 2025 · Completed: Dec 31, 2029
5 conditions
1 sponsor
1 location
NCT07042581
A Study of Revaree Plus in People With Breast Cancer
PHASE4
Recruiting
60 participants
Started: Jun 20, 2025 · Completed: Jun 20, 2029
11 conditions
1 sponsor
7 locations
NCT06977711
Loncastuximab and Roflumilast Added to R-CHOP (Lo-(Rituximab and Roflumilast) RR-CHOP) for Naïve High-Risk Diffuse Large B-cell Lymphoma (DLBCL)
PHASE1
Recruiting
10 participants
Started: Jun 20, 2025 · Completed: Jul 31, 2026
1 condition
1 sponsor
2 locations
NCT07015515
PAPE Effect With Blood Flow Restriction and Push-Up Exercise (Post-Activation Performance Enhancement)
NA
Recruiting
30 participants
Started: Jun 20, 2025 · Completed: Aug 20, 2025
1 condition
1 sponsor
1 location
NCT07020390
Effect of Anesthesia Techniques on Quality of Recovery Scores in HOLEP Surgery
N/A
Recruiting
450 participants
Started: Jun 20, 2025 · Completed: Jun 15, 2026
5 conditions
1 sponsor
1 location
NCT07125391
Chemotherapy Combined With Propranolol Hydrochloride as Neoadjuvant Therapy for Advanced High-grade Serous Ovarian Cancer
PHASE2
Recruiting
40 participants
Started: Jun 20, 2025 · Completed: Jun 30, 2027
1 condition
1 sponsor
1 location
NCT07087808
Digital Wellness Nurse - FIT Families: Virtual Family Intervention for Adolescent Obesity
NA
Recruiting
32 participants
Started: Jun 20, 2025 · Completed: Dec 31, 2025
1 condition
2 sponsors
1 location
NCT07021313
Deliver mOre aPplications for More Durable Pulmonary Vein IsOlation
NA
Recruiting
378 participants
Started: Jun 20, 2025 · Completed: Jun 30, 2028
1 condition
1 sponsor
1 location
NCT07078591
Venetoclax-containing Therapy Combined With Microtransplant for Newly Diagnosed AML
PHASE2
Recruiting
50 participants
Started: Jun 20, 2025 · Completed: Jun 30, 2031
1 condition
1 sponsor
1 location
NCT07017972
Data Collection and Professional Simulated Use Study to Develop an Embryo Quality Artificial Intelligence (AI) Model
N/A
Recruiting
4,000 participants
Started: Jun 20, 2025 · Completed: Jun 20, 2027
1 condition
1 sponsor
1 location
NCT06965465
A Study to Learn How Different Amounts of the Study Medicine Called PF-07999415 Are Tolerated and Act in the Body in Healthy Adults
PHASE1
Recruiting
53 participants
Started: Jun 20, 2025 · Completed: Jun 4, 2026
1 condition
1 sponsor
1 location
NCT06987643
A Clinical Study to Investigate the Effect of Oral Neflamapimod on Motor Recovery After Acute Ischaemic Stroke
PHASE2
Recruiting
90 participants
Started: Jun 20, 2025 · Completed: Jun 28, 2026
2 conditions
2 sponsors
11 locations
NCT07156552
Protein Supplementation and Resistance Training to Prevent Fat-Free Mass Loss Following Metabolic-Bariatric Surgery
NA
Recruiting
400 participants
Started: Jun 20, 2025 · Completed: Jun 30, 2027
2 conditions
4 sponsors
2 locations
NCT07027644
The Synergistic Effects of Integrated Neuromuscular Inhibition Technique and Dry Cupping Therapy on Pain Modulation and Functional Recovery on Myofascial Trigger Points of Upper Trapezius
NA
Recruiting
130 participants
Started: Jun 20, 2025 · Completed: Sep 20, 2025
1 condition
1 sponsor
1 location
NCT06872684
Safety and Efficacy of Endovascular Treatment of Intracranial Aneurysms With Surpass Elite With GUARDian Flow Diverter (GUARD)
NA
Recruiting
183 participants
Started: Jun 20, 2025 · Completed: Mar 31, 2028
2 conditions
1 sponsor
2 locations
NCT07025434
Effects of Hip Bump Manipulation Versus Sham Treatment in Healthy Adults
NA
Recruiting
60 participants
Started: Jun 20, 2025 · Completed: May 31, 2026
2 conditions
1 sponsor
1 location
Previous
1
More pages
90
91
92
93
94
95
96
More pages
1333
Next